Advisor Group Holdings, Inc. Roivant Sciences Ltd. Transaction History
Advisor Group Holdings, Inc.
- $42.2 Billion
- Q3 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,081 shares of ROIV stock, worth $36,016. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,081
Previous 2,162
42.51%
Holding current value
$36,016
Previous $22,000
59.09%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ROIV
# of Institutions
312Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$771 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$769 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$632 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$487 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$413 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.23B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...